Info Marzahn Hellersdorf Aktuelle Nachrichten über BIONTECH-Aktie nach Quartalszahle
BioNTech’s quarterly figures have had a negative impact on the stock price, leading to a drop below $100, with the current value at $96.720. A short position has been opened, which is currently in profit.
The stock has fallen below the support level at $104.72, indicating the possibility of a further downward movement towards the retracement level at $49.78. However, if the stock rises above $104.72, a buy signal would be generated.
It is likely that there will be a significant downward movement.
Total Student. Web-Guru. Kaffee-Enthusiast. Leser. Nicht entschuldigender Organisator. Bieranwalt.”